TP53 alterations and p53 expression in borderline ovarian tumors (BOTs) in humans

Semczuk Andrzei; Mrozek Artur; Semczuk-Sikora Anna; Galczynski Krzysztof; Lewkowicz Dorota; Nowakowski Lukasz; Postawski Krzysztof

首页> 外文期刊>International journal of molecular medicine >TP53 alterations and p53 expression in borderline ovarian tumors (BOTs) in humans

【24h】

TP53 alterations and p53 expression in borderline ovarian tumors (BOTs) in humans

机译：人类交界性卵巢肿瘤（BOT）中的TP53改变和p53表达

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of molecular medicine 》 |2016年第1期| 共1页
作者
Semczuk Andrzei; Mrozek Artur; Semczuk-Sikora Anna; Galczynski Krzysztof; Lewkowicz Dorota; Nowakowski Lukasz; Postawski Krzysztof;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学 ;
关键词

相似文献

外文文献
中文文献
专利

1. TP53 alterations and p53 expression in borderline ovarian tumors (BOTs) in humans [J] . Semczuk Andrzei, Mrozek Artur, Semczuk-Sikora Anna, International journal of molecular medicine . 2016 ,第Suppla1期

机译：人类交界性卵巢肿瘤（BOT）中的TP53改变和p53表达
2. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study [J] . Vang Russell, Levine Douglas A., Soslow Robert A., International journal of gynecological pathology: Official journal of the International Society of Gynecological Pathologists . 2016 ,第1期

机译：TP53的分子改变是卵巢高级别浆液性癌的定义特征：癌症基因组图谱卵巢研究中缺乏TP53突变的病例的回顾。
3. TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas. [J] . Skomedal H, Kristensen GB, Abeler VM, Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland . 1997 ,第2期

机译：TP53蛋白积累和基因突变与卵巢交界性肿瘤和I期癌中MDM2蛋白的过表达有关。
4. The Large-scale Analysis of Protein Expression in Human Ovarian Tumor Samples by LC-MS/MS/MS [C] . Anthony Possemato, Sean Beausoleil, Klarisa Rikova, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：LC-MS / MS / MS的人卵巢肿瘤样品中蛋白质表达的大规模分析
5. Tp53 and Hras Influence on HPV16 E7 Expression in HPV16-Transformed Human Keratinocytes [D] . Delva, Nella Christie 2015

机译：Tp53和Hras对HPV16转化的人类角质形成细胞中HPV16 E7表达的影响
6. The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review [O] . Andrzej Semczuk, Marek Gogacz, Anna Semczuk-Sikora, 2017

机译：TP53改变和p53表达在交界性卵巢肿瘤中的假定作用-与临床病理特征和预后的关系：综述
7. Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer [O] . Erdem Johanna Samulin, Skaug Vidar, Bakke Per S., 2016

机译：TP53的突变会增加SOX2拷贝数改变的风险，而TP53的沉默会降低非小细胞肺癌中SOX2的表达
8. Modeling Human Epithelial Ovarian Cancer in Mice by Alteration of Expression of the Expression of the BRCA1 and/p53 Genes [R] . Connolly, D. C. 2006

机译：通过改变BRCa1和/ p53基因表达对小鼠人卵巢上皮性癌的建模

TP53 alterations and p53 expression in borderline ovarian tumors (BOTs) in humans

著录项

相似文献

相关主题

期刊订阅